| Drug Name |
Acebutolol hydrochloride |
| Drug ID |
BADD_D00020 |
| Description |
A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action. |
| Indications and Usage |
For the management of hypertension and ventricular premature beats in adults. |
| Marketing Status |
approved; investigational |
| ATC Code |
C07AB04 |
| DrugBank ID |
DB01193
|
| KEGG ID |
D00597
|
| MeSH ID |
D000070
|
| PubChem ID |
441307
|
| TTD Drug ID |
D0HD9K
|
| NDC Product Code |
52932-0719; 65162-670; 58159-081; 65162-669; 62559-255; 51407-666; 42291-010; 62559-256; 50268-050; 53746-669; 51927-2906; 68069-0009; 53746-670; 51407-667 |
| UNII |
B025Y34C54
|
| Synonyms |
Acebutolol | Acetobutolol | Acebutolol Hydrochloride | M&B-17803 A | M&B 17803 A | M&B17803 A | M & B 17803A | Neptal | Prent | Rhotral | Sectral | Monitan | Apo-Acebutolol | Apo Acebutolol | ApoAcebutolol | Novo-Acebutolol | Novo Acebutolol | NovoAcebutolol |
